A carregar cotações...
Previsão
O preço-alvo médio dos analistas é € 15,43 (+1.853,16%). A mediana é € 15,43 (+1.853,16%).
| Comprar |
9 |
| Manter |
4 |
| Vender |
0 |
Discussões na comunidade
Ainda não há nenhuma discussão sobre este ativo.
Iniciar discussãoNotícias Ir para o feed de notícias
American Vanguard boosts margins in Q1 2026 after restructuring
American Vanguard beat expectations in Q1 2026 with net revenues of $123.6 million and raised adjusted EBITDA by 245% to $10.3 million. Gross margin improved by 500 basis points to 31%, driven by a stronger US business (+17%) and a more margin-accretive product mix, while international business temporarily declined by 7%. Net debt climbed to $195.7 million (Net Leverage 4.6x); the company refinanced its credit line into a multi-year loan structure and plans to reduce Net Leverage to 3.0x by 2028. As growth levers, American Vanguard is focusing on operational efficiency and an innovation pipeline with over 50 planned product launches and the goal of achieving roughly $100 million in additional annual revenue by 2030. » Mais em de.investing.com
American Vanguard underperforms despite operational turnaround
Riverwater Partners flagged American Vanguard as a quarterly performance detractor despite management-led improvements. Since a new CEO took over, inventory fell about 20% year‑over‑year, gross margin widened to 29% from 15%, and adjusted EBITDA rose to $8 million from $2 million. Riverwater says the company’s operating profile is materially stronger, though the stock has moved opposite to those improvements amid micro‑cap market inefficiencies. » Mais em finance.yahoo.com
American Vanguard appoints Mike DiPaola as CCO and relocates headquarters to Irvine
American Vanguard names Mike DiPaola chief commercial officer with a focus on business strategy and execution in North America; DiPaola has been with the company since February 2025 and has more than 25 years of experience in the agricultural sector. The company plans to move its headquarters from Newport Beach to Discovery Park in Irvine and complete the relocation by the end of Q2 2026. As part of an operational realignment, American Vanguard is closing non-core branches across its sites, while the stock has fallen sharply over the past three months and is down around 20% year-to-date. » Mais em de.investing.com
American Vanguard improves profitability, stock falls after missed EPS forecast
American Vanguard reported Q3 2025 revenue of $119m (+1%) and a marked improvement in profitability: adjusted EBITDA rose 350% and gross profit margin climbed to 29% (year earlier 15%). Despite cost cuts and operational efficiency, EPS missed expectations at -$0.08, sending the stock down about 7% in pre-market trading. The company adjusted full-year revenue guidance to $520–535m and is targeting adjusted EBITDA of $40–44m for 2025, expects higher shipment volumes in 2026, and highlights strategic initiatives. Risks remain trade tensions with China, competition from generics and supply-chain issues. » Mais em de.investing.com
Vanguard announces dividend payments for more than 40 ETFs in September 2025
Vanguard Funds PLC has announced dividends for more than 40 ETFs; the payment date is October 1 and the record date is September 19, 2025. For equity ETFs, the FTSE Emerging Markets UCITS ETF (USD) Distributing leads with $0.530639 per share, followed by the FTSE All-World High Dividend Yield UCITS ETF with $0.479961. Among bond ETFs, the USD Emerging Government Bond UCITS ETF pays $0.192252 and the US Corporate Bond UCITS ETF $0.179145 per share; the Germany All Cap UCITS ETF shows no distribution for this period. » Mais em de.investing.com
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | setembro de 2026 | YoY |
|---|---|---|
| Receitas | 95,68 mi | 5,89% |
| Ganho bruto | 23,18 mi | 20,51% |
| Ganho líquido | -15,6 mi | 48,12% |
| EBITDA | -2,97 mi | 14,90% |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 23,49 mi |
Número de ações | 29,55 mi |
Máximo/mínimo de 52 semanas | € 5,04 - € 0,73 |
| Dividendos | Não |
Beta | 1,56 |
PER (PE Ratio) | -0,43 |
PEG (PEG Ratio) | -0,02 |
P/VC (PB Ratio) | 0,15 |
P/V (PS Ratio) | 0,05 |
Perfil da empresa
A American Vanguard Corporation, através das suas subsidiárias, desenvolve, fabrica e comercializa produtos químicos especializados para utilizações agrícolas, comerciais e de consumo nos Estados Unidos e internacionalmente. Fabrica e formula produtos químicos, incluindo inseticidas, fungicidas, herbicidas, moluscicidas, produtos de saúde do solo, nutrição vegetal, reguladores de crescimento e fumigantes de solo, em formas líquida, em pó e granulada, para culturas, relvados e plantas ornamentais, e para a proteção da saúde humana e animal. A empresa também comercializa, vende e distribui produtos químicos e biológicos de utilização final para aplicações em culturas; e distribui produtos químicos para os mercados de relvados e plantas ornamentais. Distribui os seus produtos através de empresas de distribuição nacionais e de grupos de compra ou cooperativas; e através de escritórios de vendas, executivos de força de vendas, agentes de vendas e distribuidores detidos na totalidade. A empresa foi constituída em 1969 e tem sede em Newport Beach, Califórnia.
| Nome | American Vanguard Co. |
| CEO | Douglas A. Kaye |
| Sede | Newport Beach,
ca EUA |
| Site | |
| Setor | Materiais básicos |
| Indústria | Produtos químicos |
| Entrada em bolsa | 03/03/1987 |
| Colaboradores | 739 |
Análise aprofundada
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
NYSE | AVD |
Frankfurt | AVJ.F |
Düsseldorf | AVJ.DU |